Health Law Section

American Bar Association > ABA Groups
header

Four Star Premier Section Sponsor

brg_logo

 

 

Stay Connected

  

  • Message from the Chair

  • Stark & AKS Toolkit

  • Publications

Advertisement

  • Join Us

  • Upcoming Events

Highlights

Physicians Legal Issues

The ABA Health Law Section presents its annual Physicians Legal Issues Conference on June 13-15, 2013. Join attorneys and physicians in downtown Chicago to explore cutting-edge issues unique to physicians and their counsel in today’s healthcare environment. 

Click here for more information

Free HIPAA Megarule Redline

The Section is pleased to provide you with a redline of the changes in the final HIPAA omnibus rules. Using the redline, you can quickly view how the omnibus rules implicate a particular issue. This tool will be invaluable for health lawyers who are working through the implications of the regulations.

Click here for more information

Health Law Section Announces Slate of 2013-2014 Officers and Council

The ABA Health Law Section's Nominating Committee is pleased to announce the slate of candidates for Officers and Council members to be voted on by the membership at the Annual Meeting, August 10, in San Francisco, CA.

Click here for more information
News and Information

HIPAA Megarule eSource Special Edition Part 2

With the  publication of the HIPAA Megarule, the ABA eSource Editorial Board, in conjunction with the Section's eHealth, Privacy & Security Interest Group, is publishing a special edition of the ABA Health eSource.

Read more.

How to Kick-Off a Successful Health Law Career

The Section is excited to announce our Law Student career podcast, "How to Kick-Off a Successful Health Law Career." In this podcast, we discuss how to enter the field of health law and be successful.

 

Click here for more information.

Cells as Drugs: FDA Regulation of an Individual's Cells

A decision by the US District Court, holding that adult stem cells derived from an individual and used for therapy in that individual are drugs, has created controversy as to the jurisdiction of the FDA and its impact on innovation for cell-based therapies.

Click here for more information

  • ABA Job Board

  • Welcome Law Students

  • Breast Cancer Task Force

  • Books